(Q40272664)

English

Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination

scientific article published on 5 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Vaccinia virus

1 reference

based on heuristic

inferred from title

smallpox vaccination

0 references

Geoffrey Lilley Smith

4

object named as

Geoffrey L Smith

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Mike M Pütz

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Claire M Midgley

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Mansun Law

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

5 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Nature Medicine

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1310-1315

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

https://scigraph.springernature.com/pub.10.1038/nm1457

0 references

Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

21 January 2018

Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

21 January 2018

Cellular and humoral immunity against vaccinia virus infection of mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

21 January 2018

The formation and function of extracellular enveloped vaccinia virus

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

21 January 2018

Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

21 January 2018

The antibody response in man following infection with viruses of the pox group. II. Antibody response following vaccination

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

21 January 2018

Duration of antiviral immunity after smallpox vaccination

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Ligand-induced and nonfusogenic dissolution of a viral membrane

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model.

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutralizing and protective antibodies directed against vaccinia virus envelope antigens

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody neutralization of the extracellular enveloped form of vaccinia virus

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactions to small pox vaccine in naïve and previously-vaccinated individuals

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to smallpox vaccine in persons immunized in the distant past

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccinia virus cores are transported on microtubules

1 reference

https://api.crossref.org/works/10.1038%2FNM1457

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40272664&oldid=1892122935"